Cell-fate determination by ubiquitin-dependent regulation of translation

Nature

Volumn 525, Issue 7570, 2015, Pages 523-527

  Werner, Achim ^a   Iwasaki, Shintaro ^a   McGourty, Colleen A ^a   Medina Ruiz, Sofia ^a   Teerikorpi, Nia ^a   Fedrigo, Indro ^a   Ingolia, Nicholas T ^a   Rape, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; UBIQUITIN; UBIQUITIN LIGASE CUL3; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CUL3 PROTEIN, HUMAN; CULLIN; KBTBD8 PROTEIN, HUMAN; NOLC1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TCOF1 PROTEIN, HUMAN;

CELLS AND CELL COMPONENTS; CHROMOSOME; ENZYME ACTIVITY; FROG; HOMINID; PROTEIN; REGENERATION; SUBSTRATE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MANDIBULOFACIAL DYSOSTOSIS; MUTATION; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; UBIQUITINATION; ANIMAL; CHEMISTRY; CYTOLOGY; EMBRYONIC STEM CELL; GENETICS; METABOLISM; PROTEIN SYNTHESIS; PROTEOMICS; XENOPUS;

METAZOA; VERTEBRATA; XENOPUS TROPICALIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DIFFERENTIATION; CULLIN PROTEINS; EMBRYONIC STEM CELLS; HUMANS; MANDIBULOFACIAL DYSOSTOSIS; NEURAL CREST; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; PROTEOMICS; RIBOSOMES; RNA POLYMERASE I; UBIQUITIN; UBIQUITINATION; XENOPUS;

EID: 84942525608     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14978     Document Type: Article

References (36)

1. Gurdon, J. B. The egg and the nucleus: a battle for supremacy. Development 140, 2449-2456 (2013).
2. The Treacher Collins Syndrome Collaborative Group. Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nature Genet. 12, 130-136 (1996).
3. Dixon, J. et al. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc. Natl Acad. Sci. USA 103, 13403-13408 (2006).
4. Petroski, M. D., Deshaies, R. J. Function and regulation of cullin-RING ubiquitin ligases. Nature Rev. Mol. Cell Biol. 6, 9-20 (2005).
5. Silverman, J. S., Skaar, J. R.& Pagano,M. SCF ubiquitin ligases in themaintenance of genome stability. Trends Biochem. Sci. 37, 66-73 (2012).
6. Wang, Y. et al. Deletion of the Cul1 gene in mice causes arrest in early embryogenesis and accumulation of cyclin E. Curr. Biol. 9, 1191-1194 (1999).
7. Arai, T. et al. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc. Natl Acad. Sci. USA 100, 9855-9860 (2003).
8. Singer, J. D., Gurian-West, M., Clurman, B., Roberts, J. M. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13, 2375-2387 (1999).
9. Jiang,B. et al. Lack of Cul4b, an E3 ubiquitin ligase component, leads to embryonic lethality and abnormal placental development. PLoS ONE 7, e37070 (2012).
10. Voigt, J., Papalopulu, N. A dominant-negative form of the E3 ubiquitin ligase Cullin-1 disrupts the correct allocation of cell fate in the neural crest lineage. Development 133, 559-568 (2006).
11. Jin, L. et al. Ubiquitin-dependent regulation of COPII coat size and function. Nature 482, 495-500 (2012).
12. Lander, R., Nordin, K., LaBonne, C. The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, Sip1. J. Cell Biol. 194, 17-25 (2011).
13. Skaar, J. R., Pagan, J. K., Pagano, M. Mechanisms and function of substrate recruitment by F-box proteins. Nature Rev. Mol. Cell Biol. 14, 369-381 (2013).
14. Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nature Genet. 44, 685-689 (2012).
15. Louis-Dit-Picard, H. et al. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nature Genet. 44, 456-460 (2012).
16. Welcker, M., Clurman, B. E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nature Rev. Cancer 8, 83-93 (2008).
17. Yanai, I., Peshkin, L., Jorgensen, P., Kirschner, M. W. Mapping gene expression in two Xenopus species: evolutionary constraints and developmental flexibility. Dev. Cell 20, 483-496 (2011).
18. Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnol. 27, 275-280 (2009).
19. Dauwerse, J. G. et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nature Genet. 43, 20-22 (2011).
20. Jones, N. C. et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nature Med. 14, 125-133 (2008).
21. Price, J. C., Guan, S., Burlingame, A., Prusiner, S. B., Ghaemmaghami, S. Analysis of proteome dynamics in the mouse brain. Proc. Natl Acad. Sci. USA 107, 14508-14513 (2010).
22. Cambridge,S.B. et al.Systems-wide proteomic analysis inmammaliancells reveals conserved, functional protein turnover. J. Proteome Res. 10, 5275-5284 (2011).
23. Tuck, A. C., Tollervey, D. A transcriptome-wide atlas of RNP composition reveals diverse classes of mRNAs and lncRNAs. Cell 154, 996-1009 (2013).
24. Jack, K. et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell 44, 660-666 (2011).
25. Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902-906 (2006).
26. Kondrashov, N. et al. Ribosome-mediated specificity in HoxmRNA translation and vertebrate tissue patterning. Cell 145, 383-397 (2011).
27. Xue, S., Barna, M. Specialized ribosomes: a new frontier in gene regulation and organismal biology. Nature Rev. Mol. Cell Biol. 13, 355-369 (2012).
28. McCann, K. L.& Baserga, S. J. Genetics. Mysterious ribosomopathies. Science 341, 849-850 (2013).
29. Freed,E. F., Prieto, J. L.,McCann,K. L.,McStay, B.&Baserga,S. J.NOL11,implicated in the pathogenesis of North American Indian childhood cirrhosis, is required for pre-rRNA transcription and processing. PLoS Genet. 8, e1002892 (2012).
30. Sondalle, S. B., Baserga, S. J. Human diseases of the SSU processome. Biochim. Biophys. Acta 1842, 758-764 (2014).
31. Rape, M., Reddy, S. K., Kirschner, M. W. The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124, 89-103 (2006).
32. Jin, L., Williamson, A., Banerjee, S., Philipp, I., Rape, M. Mechanism of ubiquitinchain formation by the human anaphase-promoting complex. Cell 133, 653-665 (2008).
33. Khokha, M. K. et al. Techniques and probes for the study of Xenopus tropicalis development. Develop. Dyn. 225, 499-510 (2002).
34. Sowa, M. E., Bennett, E. J., Gygi, S. P., Harper, J. W. Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403 (2009).
35. Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M., Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nature Protocols 7, 1534-1550 (2012).
36. Anders, S., Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).